Ventricular oversensing in 518 patients with implanted cardiac defibrillators: Incidence, complications, and solutions

Europace

Volumn 9, Issue 11, 2007, Pages 1041-1047

  Rauwolf, T ^a   Guenther, M ^a   Hass, N ^a   Schnabel, A ^a   Bock, M ^a   Braun, M U ^a   Strasser, R H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Complication; ICD; Ventricular oversensing

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CONVULSIVE THERAPY; DEFIBRILLATOR; ELECTROMAGNETIC FIELD; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; PACEMAKER ELECTRODE; PRIORITY JOURNAL; CARDIOVERSION; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; HEART VENTRICLE; INCIDENCE; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; ELECTROMAGNETIC FIELDS; FEMALE; HEART VENTRICLES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; VENTRICULAR FIBRILLATION;

EID: 40049087455     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum195     Document Type: Article

References (34)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.
5. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001;22:1374-450.
6. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
7. DeCaprio V, Hurzeler P, Furman S. A comparison of unipolar and bipolar electrograms for cardiac pacemaker sensing. Circulation 1977;56:750-5.
8. Secemsky SI, Hauser RG, Denes P, Edwards LM. Unipolar sensing abnormalities: incidence and clinical significance of skeletal muscle interference and undersensing in 228 patients. Pacing Clin Electrophysiol 1982;5:10-9.
9. Schulte B, Sperzel J, Carlsson J, Dursch M, Erdogan A, Pitschner HF et al. Inappropriate arrhythmia detection in implantable defibrillator therapy due to oversensing of diaphragmatic myopotentials. J Interv Card Electrophysiol 2001;5:487-93.
10. Lin D, Dixit S, Russo AM, Hsia HH. Total failure to sense ventricular fibrillation with inappropriate defibrillator sensitivity adjustment. Pacing Clin Electrophysiol 2004;27:1321-3.
11. Weretka S, Michaelsen J, Becker R, Karle CA, Voss F, Hilbel T et al. Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 2003;26:65-70.
12. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999;22:711-20.
13. Porres JM, Brugada J, Marco P, Garcia F, Azcarate B. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome. Pacing Clin Electrophysiol 2004;27:1563-5.
14. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27:924-32.
15. Hsu SS, Mohib S, Schroeder A, Deger FT. Twave oversensing in implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004;11:67-72.
16. Washizuka T, Chinushi M, Tagawa M, Kasai H, Watanabe H, Hosaka Y et al. Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias. Jpn Circ J 2001;65:927-30.
17. Duru F, Bauersfeld U, Candinas R. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion. Europace 2001;3:80-4.
18. Wiegand UK, Bode F, Bonnemeier H, Tolg R, Peters W, Katus HA. Incidence and predictors of pacemaker dysfunction with unipolar ventricular lead configuration. Can we identify patients who benefit from bipolar electrodes? Pacing Clin Electrophysiol 2001;24:1383-8.
19. Sandler MJ, Kutalek SP. Inappropriate discharge by an implantable cardioverter defibrillator: recognition of myopotential sensing using telemetered intracardiac electrograms. Pacing Clin Electrophysiol 1994;17:665-71.
20. Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: two case reports. J Cardiovasc Electrophysiol 1998;9:767-72.
21. Mann DE, Otto L, Kelly PA, Reiter MJ. Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverter-defibrillators. Am J Cardiol 2000;85:1380-2.
22. Grimm W, Menz V, Hoffmann J, Timmann U, Funck R, Moosdorf R et al. Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol 1999;22:206-11.
23. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
24. Wollmann CG, Bocker D, Loher A, Kobe J, Scheld HH, Breithardt GE et al. Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol 2005;28:795-800.
25. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 2003;41:73-80.
26. Shivkumar K, Feliciano Z, Boyle NG, Wiener I. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection. J Cardiovasc Electrophysiol 2000;11:1285-8.
27. Geiger MJ, O'Neill P, Sharma A, Skadsen A, Zimerman L, Greenfield RA et al. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. Pacing Clin Electrophysiol 1997;20:624-30.
28. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
29. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999;22:711-20.
30. Saeed M, Jin A, Pontone G, Higgins S, Gold M, Harari D et al. Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators. Ann Noninvasive Electrocardiol 2003;8:219-26.
31. Messali A, Thomas O, Chauvin M, Coumel P, Leenhardt A. Death due to an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2004;15:953-6.
32. Souques M. The influence of non-ionizing electromagnetic fields on implantable cardiac medical devices. Presse Med 2004;33:1611-5.
33. Calkins H, Brinker J, Veltri EP, Guarnieri T, Levine JH. Clinical interactions between pacemakers and automatic implantable cardioverter- defibrillators. J Am Coll Cardiol 1990;16:666-73.
34. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.